Show simple item record

dc.contributor.authorGreaves, Mike
dc.date.accessioned2014-10-01T09:20:04Z
dc.date.available2014-10-01T09:20:04Z
dc.date.issued2005-10-25
dc.identifier.citationGreaves , M 2005 , ' Pharmacogenetics in the management of coumarin anticoagulant therapy : the way forward or an expensive diversion? ' PLoS Medicine , vol. 2 , no. 10 , e342 . DOI: 10.1371/journal.pmed.0020342en
dc.identifier.issn1549-1277
dc.identifier.otherPURE: 377192
dc.identifier.otherPURE UUID: 3bdf703c-8fc9-4006-af09-7a5d496cff6d
dc.identifier.otheraberdeen_publication: 9697
dc.identifier.otherScopus: 27644541797
dc.identifier.urihttp://hdl.handle.net/2164/3652
dc.format.extent2en
dc.language.isoeng
dc.relation.ispartofPLoS Medicineen
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0/en
dc.subjectR Medicineen
dc.subject.lccRen
dc.titlePharmacogenetics in the management of coumarin anticoagulant therapy : the way forward or an expensive diversion?en
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen, Medicine, Medical Sciences & Nutritionen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1371/journal.pmed.0020342


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record